Lavinia Perquim, Marco Antônio de Bastiani, Luiza Santos Machado, Wyllians Vendramini Borelli, Guilherme Povala, Thomas Hugentobler Schlickmann, Tharick A. Pascoal, Pedro Rosa‐Neto, Alexandre Santos Cristino, Eduardo R. Zimmer
{"title":"Associations between peripheral blood DNA methylation and FDG‐PET signal in AD individuals","authors":"Lavinia Perquim, Marco Antônio de Bastiani, Luiza Santos Machado, Wyllians Vendramini Borelli, Guilherme Povala, Thomas Hugentobler Schlickmann, Tharick A. Pascoal, Pedro Rosa‐Neto, Alexandre Santos Cristino, Eduardo R. Zimmer","doi":"10.1002/alz.092675","DOIUrl":null,"url":null,"abstract":"BackgroundEpigenetics plays a crucial role in regulating genetic transcription and responding to environmental and lifestyle changes without altering the DNA sequence. Their dysregulation is associated with AD, presenting potential as blood biomarkers. However, no study has evaluated whether peripheral blood (PB) epigenetic biomarkers are associated with brain metabolism, indexed by FDG‐PET, a classic Imaging AD biomarker. Thus, we explore the associations between PB DNA methylation and FDG‐PET signal in the brain of cognitively unimpaired (CU) and AD individuals.MethodWe evaluated CU=43 and AD=122 individuals from the ADNI cohort who underwent FDG‐PET imaging and PB DNA methylation analysis. Methylation data were analyzed using the minfi R package. Correlation analysis was performed with the statistically significant differentially methylated regions (DMRs) (p<0.005) and the regional FDG‐PET standardized uptake value ratio (SUVRs) values extracted with the DKT atlas. Voxel‐wise associations between FDG‐PET and DMRs were tested using linear regressions accounting for group, gender, age, and APOE4 status. The analysis was corrected for multiple comparisons using cluster‐wise RFT (p<0.05).ResultWe identified 478 DMRs (Figure 1), multiple of them significantly associated with regional FDG‐PET SUVRs (Figure 2). The voxel‐based analysis demonstrated that DMR cg02041677, located in the ATE1 gene, was negatively associated with FDG‐PET signal in the left hippocampus, right orbitofrontal gyrus, and right medial temporal gyrus (tmax=‐4.28, ‐4.04, ‐3.58, respectively; p‐value<0.001). The cg11128212, in the intron, nearby two lncRNA (ENSG00000289046, ENSG00000274591), was positively associated with brain metabolism in the left hippocampus, left temporal pole, and left middle temporal gyrus (tmax=4.08, 3.98, 3.80, respectively; p‐value<0.001) while the cg11901271, located in intron, nearby of a LncRNA (ENSG00000287358), showed positive correlations with FDG‐PET in the Left hippocampus (tmax=5.35, respectively; p‐value<0.001) (Figure 3).ConclusionHere, we show that PB DMRs exhibited a significant pattern of association with brain glucose metabolism in vulnerable AD regions. LncRNAs are important transcriptional regulators, the methylation could impact gene expression in AD and present potential as blood biomarkers.","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"6 1","pages":""},"PeriodicalIF":13.0000,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer's & Dementia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/alz.092675","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
BackgroundEpigenetics plays a crucial role in regulating genetic transcription and responding to environmental and lifestyle changes without altering the DNA sequence. Their dysregulation is associated with AD, presenting potential as blood biomarkers. However, no study has evaluated whether peripheral blood (PB) epigenetic biomarkers are associated with brain metabolism, indexed by FDG‐PET, a classic Imaging AD biomarker. Thus, we explore the associations between PB DNA methylation and FDG‐PET signal in the brain of cognitively unimpaired (CU) and AD individuals.MethodWe evaluated CU=43 and AD=122 individuals from the ADNI cohort who underwent FDG‐PET imaging and PB DNA methylation analysis. Methylation data were analyzed using the minfi R package. Correlation analysis was performed with the statistically significant differentially methylated regions (DMRs) (p<0.005) and the regional FDG‐PET standardized uptake value ratio (SUVRs) values extracted with the DKT atlas. Voxel‐wise associations between FDG‐PET and DMRs were tested using linear regressions accounting for group, gender, age, and APOE4 status. The analysis was corrected for multiple comparisons using cluster‐wise RFT (p<0.05).ResultWe identified 478 DMRs (Figure 1), multiple of them significantly associated with regional FDG‐PET SUVRs (Figure 2). The voxel‐based analysis demonstrated that DMR cg02041677, located in the ATE1 gene, was negatively associated with FDG‐PET signal in the left hippocampus, right orbitofrontal gyrus, and right medial temporal gyrus (tmax=‐4.28, ‐4.04, ‐3.58, respectively; p‐value<0.001). The cg11128212, in the intron, nearby two lncRNA (ENSG00000289046, ENSG00000274591), was positively associated with brain metabolism in the left hippocampus, left temporal pole, and left middle temporal gyrus (tmax=4.08, 3.98, 3.80, respectively; p‐value<0.001) while the cg11901271, located in intron, nearby of a LncRNA (ENSG00000287358), showed positive correlations with FDG‐PET in the Left hippocampus (tmax=5.35, respectively; p‐value<0.001) (Figure 3).ConclusionHere, we show that PB DMRs exhibited a significant pattern of association with brain glucose metabolism in vulnerable AD regions. LncRNAs are important transcriptional regulators, the methylation could impact gene expression in AD and present potential as blood biomarkers.
期刊介绍:
Alzheimer's & Dementia is a peer-reviewed journal that aims to bridge knowledge gaps in dementia research by covering the entire spectrum, from basic science to clinical trials to social and behavioral investigations. It provides a platform for rapid communication of new findings and ideas, optimal translation of research into practical applications, increasing knowledge across diverse disciplines for early detection, diagnosis, and intervention, and identifying promising new research directions. In July 2008, Alzheimer's & Dementia was accepted for indexing by MEDLINE, recognizing its scientific merit and contribution to Alzheimer's research.